FASN and chronic obstructive pulmonary disease: FASN is downregulated in the AMs of patients with COPD, and these AMs are enriched in PCs and CEs, which suggests that in mild-severity stages, AMs may contribute to the decrease in surfactant lipids in the alveolar space by increasing their surfactant catabolism rate (53).